Search for Topics:
Title/Keyword
Journal
Submission Status
Category
 
 
Topics
Cancer Biology and Radiation Therapy (Volume II)
Submit your Manuscript Submit your Abstract Propose a Topic

Topic Menu

► Topic Menu

Topic Editors

Radiation Oncology Department, Fox Chase Cancer Center, 333 Cottman Ave., Philadelphia, PA 19111, USA
Dr. Ka Yu Tse
Division of Gynaecology Oncology, Department of Obstetrics and Gynaecology, Queen Mary Hospital, The University of Hong Kong, Hong Kong
Department of Radiation Oncology, Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan
Center for Oral Oncology, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY 14263, USA
share announcement

Cancer Biology and Radiation Therapy (Volume II)

Abstract submission deadline
15 August 2025
Manuscript submission deadline
16 October 2025
Viewed by
244

Topic Information

Dear Colleagues,

This Topic is the second edition of the Topic “Cancer Biology and Radiation Therapy”, available at https://www.mdpi.com/topics/CBART.

Radiation therapy or radiotherapy, often abbreviated as RT, RTx, or XRT, uses ionizing radiation, generally provided as part of cancer treatment to control or kill malignant cells and usually delivered by a linear accelerator. Radiation therapy may be curative in several types of cancer if they are localized to one area of the body. It may also be used as part of adjuvant therapy to prevent tumor recurrence after surgery to remove a primary malignant tumor (for example, early stages of breast cancer). Radiation therapy is synergistic with chemotherapy and has been used before, during, and after chemotherapy in susceptible cancers. The subspecialty of oncology concerned with radiotherapy is called radiation oncology.

Prof. Dr. Chang Ming Charlie Ma
Dr. Ka Yu Tse
Dr. Ming-Yii Huang
Dr. Mukund Seshadri
Topic Editors

Keywords

  • cancer biology
  • radiation therapy
  • cancer therapy
  • radiation oncology
  • adjuvant therapy

 

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Cancers
cancers 		5.2 7.4 2009 17.9 Days CHF 2900 Submit
Current Oncology
curroncol 		2.6 2.6 1994 18 Days CHF 2200 Submit
Journal of Clinical Medicine
jcm 		3.9 5.4 2012 17.9 Days CHF 2600 Submit
Medicina
medicina 		2.6 3.6 1920 19.6 Days CHF 1800 Submit
Onco
onco 		- - 2021 18.3 Days CHF 1000 Submit

Preprints.org is a multidiscipline platform providing preprint service that is dedicated to sharing your research from the start and empowering your research journey.

MDPI Topics is cooperating with Preprints.org and has built a direct connection between MDPI journals and Preprints.org. Authors are encouraged to enjoy the benefits by posting a preprint at Preprints.org prior to publication:

  1. Immediately share your ideas ahead of publication and establish your research priority;
  2. Protect your idea from being stolen with this time-stamped preprint article;
  3. Enhance the exposure and impact of your research;
  4. Receive feedback from your peers in advance;
  5. Have it indexed in Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (1 paper)

Order results
Result details
Journals
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
10 pages, 1586 KiB  
Article
Evaluation of Tumor Control and Normal Tissue Complication Probabilities in Patients Receiving Comprehensive Nodal Irradiation for Left-Sided Breast Cancer
by Christian H. Flores-Balcázar and Dulce M. Urías-Arce
Curr. Oncol. 2024, 31(6), 3189-3198; https://doi.org/10.3390/curroncol31060241 (registering DOI) - 31 May 2024
Abstract
Women with left-sided breast cancer receiving adjuvant radiotherapy have increased incidence of cardiac mortality due to ischemic heart disease; to date, no threshold dose for late cardiac/pulmonary morbidity or mortality has been established. We investigated the likelihood of cardiac death and radiation pneumonitis [...] Read more.
Women with left-sided breast cancer receiving adjuvant radiotherapy have increased incidence of cardiac mortality due to ischemic heart disease; to date, no threshold dose for late cardiac/pulmonary morbidity or mortality has been established. We investigated the likelihood of cardiac death and radiation pneumonitis in women with left-sided breast cancer who received comprehensive lymph node irradiation. The differences in dosimetric parameters between free-breathing (FB) and deep inspiration breath hold (DIBH) techniques were also addressed. Based on NTCP calculations, the probability of cardiac death was significantly reduced with the DIBH compared to the FB technique (p < 0.001). The risk of radiation pneumonitis was not clinically significant. There was no difference in coverage between FB and DIBH plans. Doses to healthy structures were significantly lower in DIBH plan than in FB plan for V20, V30, and ipsilateral total lung volume. Inspiratory gating reduces the dose absorbed by the heart without compromising the target range, thus reducing the likelihood of cardiac death. Full article
(This article belongs to the Topic Cancer Biology and Radiation Therapy (Volume II))
►▼ Show Figures

Graphical abstract

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop